{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:48:09Z","timestamp":1790099289136,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI21C1372"],"award-info":[{"award-number":["HI21C1372"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jaip.2024.12.021","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T13:36:21Z","timestamp":1735047381000},"page":"610-618.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk Factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"13","author":[{"given":"Ha Young","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Wha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Ryun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Mi","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.12.021_bib1","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/all.13765","article-title":"Immune pathomechanism and classification of drug hypersensitivity","volume":"74","author":"Pichler","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.12.021_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-018-0251-z","article-title":"A\u00a0population-based epidemiological study of anaphylaxis using national big data in Korea: trends in age-specific prevalence and epinephrine use in 2010\u20132014","volume":"14","author":"Jeong","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.021_bib3","first-page":"1663","article-title":"Cisplatin and platinum drugs at the molecular level. (Review)","volume":"10","author":"Boulikas","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jaip.2024.12.021_bib4","first-page":"1972","article-title":"Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(ii) and cis-diammine-(l,l-cyclobutanedicarboxylato)platinum(ii) differ only in the kinetics of their interaction with DNA","volume":"46","author":"Knox","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaip.2024.12.021_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1389557024605500","article-title":"Biomolecular targets for platinum antitumor drugs","volume":"2","author":"Bose","year":"2002","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.jaip.2024.12.021_bib6","series-title":"Metals in medicine","author":"Dabrowiak","year":"2017"},{"key":"10.1016\/j.jaip.2024.12.021_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1385\/CRIAI:24:3:253","article-title":"Hypersensitivity reactions to chemotherapeutic drugs","volume":"24","author":"Shepherd","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.12.021_bib8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.alit.2017.02.008","article-title":"Epidemiology of drug-induced anaphylaxis in a tertiary hospital in Korea","volume":"66","author":"Park","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2024.12.021_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4168\/aard.2020.8.1.30","article-title":"Analysis of individual case safety reports of drug-induced anaphylaxis to the Korea Adverse Event Reporting System","volume":"8","author":"Cho","year":"2020","journal-title":"Allergy Asthma Respir Dis"},{"key":"10.1016\/j.jaip.2024.12.021_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00280-010-1338-5","article-title":"Risk factors contributing to the development of carboplatin-related delayed hypersensitivity reactions in Japanese patients with gynecologic cancers","volume":"67","author":"Sugimoto","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaip.2024.12.021_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2006.10.047","article-title":"Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital","volume":"105","author":"Schwartz","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2024.12.021_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/ijgc-00009577-200807000-00003","article-title":"Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer","volume":"18","author":"Gadducci","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jaip.2024.12.021_bib13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fphar.2017.00800","article-title":"Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies","volume":"8","author":"Tai","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2024.12.021_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcms.2010.11.001","article-title":"Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias","volume":"39","author":"Knobloch","year":"2011","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jaip.2024.12.021_bib15","author":"Wells"},{"key":"10.1016\/j.jaip.2024.12.021_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jaip.2024.12.021_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"10.1016\/j.jaip.2024.12.021_bib18","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jaip.2024.12.021_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jaip.2024.12.021_bib20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.jaip.2024.12.021_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2024.12.021_bib22","author":"Borenstein"},{"key":"10.1016\/j.jaip.2024.12.021_bib23","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00432-018-2753-y","article-title":"Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer","volume":"144","author":"Altwerger","year":"2018","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jaip.2024.12.021_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00404-022-06403-9","article-title":"Risk factors for and prognosis of carboplatin-related hypersensitivity in patients with epithelial ovarian cancer","volume":"306","author":"Hwang","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jaip.2024.12.021_bib25","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/cas.12538","article-title":"Carboplatin-induced severe hypersensitivity reaction: role of IgE-dependent basophil activation and FcepsilonRI","volume":"105","author":"Iwamoto","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jaip.2024.12.021_bib26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1248\/bpb.b12-00150","article-title":"Evaluation of basophil CD203c as a predictor of carboplatin-related hypersensitivity reaction in patients with gynecologic cancer","volume":"35","author":"Iwamoto","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jaip.2024.12.021_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1078155216679028","article-title":"Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer","volume":"22","author":"Jerzak","year":"2018","journal-title":"J\u00a0Oncol Pharm Pract"},{"key":"10.1016\/j.jaip.2024.12.021_bib28","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/IGC.0b013e3181a1bf2e","article-title":"Incidence of carboplatin-related hypersensitivity reactions in Japanese patients with gynecologic malignancies","volume":"19","author":"Koshiba","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jaip.2024.12.021_bib29","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cncr.23249","article-title":"Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience","volume":"112","author":"Lafay-Cousin","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jaip.2024.12.021_bib30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0090-8258(03)00155-0","article-title":"Relationship between a history of systemic allergic reactions and risk of subsequent carboplatin hypersensitivity","volume":"89","author":"Markman","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2024.12.021_bib31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/bjc.2013.389","article-title":"Deleterious BRCA1\/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions","volume":"109","author":"Moon","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaip.2024.12.021_bib32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2006.04.002","article-title":"Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients","volume":"103","author":"Navo","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2024.12.021_bib33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ygyno.2009.10.070","article-title":"The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment","volume":"116","author":"O'Cearbhaill","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2024.12.021_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000336772","article-title":"A\u00a0search for predictive factors for hypersensitivity reactions to paclitaxel and platinum salts in chemotherapy for gynecologic pelvic neoplasms","volume":"74","author":"Piovano","year":"2012","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jaip.2024.12.021_bib35","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1177\/1078155220967988","article-title":"Predictive factors for carboplatin hypersensitivity reactions in gynecologic cancers: effect of BRCA status","volume":"27","author":"Rolfe","year":"2021","journal-title":"J\u00a0Oncol Pharm Pract"},{"key":"10.1016\/j.jaip.2024.12.021_bib36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.32429\/jkshp.2010.27.4.002","article-title":"Carboplatin hypersensitivity reactions in Korean patients with gynecologic cancers","volume":"27","author":"Seo","year":"2010","journal-title":"J\u00a0Kor Soc Health-Syst Pharm"},{"key":"10.1016\/j.jaip.2024.12.021_bib37","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/ijgc-2018-000072","article-title":"A\u00a0cohort study of hypersensitivity reaction in patients with epithelial ovarian cancer treated with carboplatin","volume":"29","author":"Sun","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jaip.2024.12.021_bib38","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1007\/s10147-021-02034-3","article-title":"Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients","volume":"26","author":"Zhu","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jaip.2024.12.021_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40521-017-0128-2","article-title":"Epidemiology and risk factors in drug hypersensitivity reactions","volume":"4","author":"Gomes","year":"2017","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2024.12.021_bib40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0959-8049(94)90489-8","article-title":"Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma","volume":"30A","author":"Morgan","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaip.2024.12.021_bib41","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","article-title":"Clinical features of hypersensitivity reactions to carboplatin","volume":"17","author":"Markman","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2024.12.021_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<183::AID-MPO4>3.0.CO;2-P","article-title":"Hypersensitivity to carboplatin in children","volume":"32","author":"Schiavetti","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jaip.2024.12.021_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000055363","article-title":"Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience","volume":"61","author":"Polyzos","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.jaip.2024.12.021_bib46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/SLA.0000000000001351","article-title":"Site and stage of colorectal cancer influence the likelihood and distribution of disease recurrence and postrecurrence survival: data from the FACS Randomized Controlled Trial","volume":"263","author":"Pugh","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.jaip.2024.12.021_bib47","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14737140.2017.1398088","article-title":"Optimizing treatment in recurrent epithelial ovarian cancer","volume":"17","author":"Corrado","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jaip.2024.12.021_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/0971-5851.133705","article-title":"Carboplatin hypersensitivity in relapsed ovarian carcinoma: a therapeutic challenge","volume":"35","author":"Pandey","year":"2014","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1016\/j.jaip.2024.12.021_bib49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1006\/gyno.2001.6331","article-title":"Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies","volume":"82","author":"Robinson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2024.12.021_bib50","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jaip.2024.12.021_bib51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2024.12.021_bib52","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer","volume":"34","author":"Tung","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2024.12.021_bib53","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jaip.2016.08.012","article-title":"Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1\/2 mutation","volume":"5","author":"Galv\u00e3o","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.12.021_bib54","first-page":"1120","article-title":"BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum (II)","volume":"58","author":"Husain","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaip.2024.12.021_bib55","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2024.12.021_bib56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00106-018-0595-1","article-title":"Reasons for the development of allergies in children","volume":"67","author":"Klimek","year":"2019","journal-title":"HNO"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824012649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824012649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:16:03Z","timestamp":1762607763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824012649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213219824012649"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.12.021","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}